IDEAYA Biosciences Inc
NASDAQ:IDYA

Watchlist Manager
IDEAYA Biosciences Inc Logo
IDEAYA Biosciences Inc
NASDAQ:IDYA
Watchlist
Price: 26.995 USD 1.48% Market Closed
Market Cap: 2.3B USD
Have any thoughts about
IDEAYA Biosciences Inc?
Write Note

Intrinsic Value

IDYA's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one IDYA stock under the Base Case scenario is 11.022 USD. Compared to the current market price of 26.995 USD, IDEAYA Biosciences Inc is Overvalued by 59%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

IDYA Intrinsic Value
11.022 USD
Overvaluation 59%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
IDEAYA Biosciences Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for IDYA cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about IDYA?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
IDEAYA Biosciences Inc

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about IDEAYA Biosciences Inc

Provide an overview of the primary business activities
of IDEAYA Biosciences Inc.

What unique competitive advantages
does IDEAYA Biosciences Inc hold over its rivals?

What risks and challenges
does IDEAYA Biosciences Inc face in the near future?

Has there been any significant insider trading activity
in IDEAYA Biosciences Inc recently?

Summarize the latest earnings call
of IDEAYA Biosciences Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for IDEAYA Biosciences Inc.

Provide P/S
for IDEAYA Biosciences Inc.

Provide P/E
for IDEAYA Biosciences Inc.

Provide P/OCF
for IDEAYA Biosciences Inc.

Provide P/FCFE
for IDEAYA Biosciences Inc.

Provide P/B
for IDEAYA Biosciences Inc.

Provide EV/S
for IDEAYA Biosciences Inc.

Provide EV/GP
for IDEAYA Biosciences Inc.

Provide EV/EBITDA
for IDEAYA Biosciences Inc.

Provide EV/EBIT
for IDEAYA Biosciences Inc.

Provide EV/OCF
for IDEAYA Biosciences Inc.

Provide EV/FCFF
for IDEAYA Biosciences Inc.

Provide EV/IC
for IDEAYA Biosciences Inc.

Show me price targets
for IDEAYA Biosciences Inc made by professional analysts.

What are the Revenue projections
for IDEAYA Biosciences Inc?

How accurate were the past Revenue estimates
for IDEAYA Biosciences Inc?

What are the Net Income projections
for IDEAYA Biosciences Inc?

How accurate were the past Net Income estimates
for IDEAYA Biosciences Inc?

What are the EPS projections
for IDEAYA Biosciences Inc?

How accurate were the past EPS estimates
for IDEAYA Biosciences Inc?

What are the EBIT projections
for IDEAYA Biosciences Inc?

How accurate were the past EBIT estimates
for IDEAYA Biosciences Inc?

Compare the revenue forecasts
for IDEAYA Biosciences Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of IDEAYA Biosciences Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of IDEAYA Biosciences Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of IDEAYA Biosciences Inc compared to its peers.

Compare the P/E ratios
of IDEAYA Biosciences Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing IDEAYA Biosciences Inc with its peers.

Analyze the financial leverage
of IDEAYA Biosciences Inc compared to its main competitors.

Show all profitability ratios
for IDEAYA Biosciences Inc.

Provide ROE
for IDEAYA Biosciences Inc.

Provide ROA
for IDEAYA Biosciences Inc.

Provide ROIC
for IDEAYA Biosciences Inc.

Provide ROCE
for IDEAYA Biosciences Inc.

Provide Gross Margin
for IDEAYA Biosciences Inc.

Provide Operating Margin
for IDEAYA Biosciences Inc.

Provide Net Margin
for IDEAYA Biosciences Inc.

Provide FCF Margin
for IDEAYA Biosciences Inc.

Show all solvency ratios
for IDEAYA Biosciences Inc.

Provide D/E Ratio
for IDEAYA Biosciences Inc.

Provide D/A Ratio
for IDEAYA Biosciences Inc.

Provide Interest Coverage Ratio
for IDEAYA Biosciences Inc.

Provide Altman Z-Score Ratio
for IDEAYA Biosciences Inc.

Provide Quick Ratio
for IDEAYA Biosciences Inc.

Provide Current Ratio
for IDEAYA Biosciences Inc.

Provide Cash Ratio
for IDEAYA Biosciences Inc.

What is the historical Revenue growth
over the last 5 years for IDEAYA Biosciences Inc?

What is the historical Net Income growth
over the last 5 years for IDEAYA Biosciences Inc?

What is the current Free Cash Flow
of IDEAYA Biosciences Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for IDEAYA Biosciences Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
IDEAYA Biosciences Inc

Current Assets 932.2m
Cash & Short-Term Investments 920m
Receivables 20k
Other Current Assets 12.2m
Non-Current Assets 307.7m
Long-Term Investments 280.1m
PP&E 26.6m
Other Non-Current Assets 911k
Current Liabilities 40.7m
Accounts Payable 12.6m
Accrued Liabilities 28.1m
Non-Current Liabilities 18.8m
Other Non-Current Liabilities 18.8m
Efficiency

Earnings Waterfall
IDEAYA Biosciences Inc

Revenue
3.9m USD
Operating Expenses
-228.7m USD
Operating Income
-224.8m USD
Other Expenses
46.6m USD
Net Income
-178.1m USD

Free Cash Flow Analysis
IDEAYA Biosciences Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

IDYA Profitability Score
Profitability Due Diligence

IDEAYA Biosciences Inc's profitability score is 13/100. The higher the profitability score, the more profitable the company is.

Exceptional Revenue Growth Forecast
Declining ROE
Negative 1-Year Revenue Growth
Declining ROIC
13/100
Profitability
Score

IDEAYA Biosciences Inc's profitability score is 13/100. The higher the profitability score, the more profitable the company is.

IDYA Solvency Score
Solvency Due Diligence

IDEAYA Biosciences Inc's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
69/100
Solvency
Score

IDEAYA Biosciences Inc's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

IDYA Price Targets Summary
IDEAYA Biosciences Inc

Wall Street analysts forecast IDYA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IDYA is 56.1 USD with a low forecast of 27.27 USD and a high forecast of 68.25 USD.

Lowest
Price Target
27.27 USD
1% Upside
Average
Price Target
56.1 USD
108% Upside
Highest
Price Target
68.25 USD
153% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for IDYA?

Click here to dive deeper.

Dividends

IDEAYA Biosciences Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for IDYA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

IDYA Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

IDEAYA Biosciences Inc Logo
IDEAYA Biosciences Inc

Country

United States of America

Industry

Biotechnology

Market Cap

2.3B USD

Dividend Yield

0%

Description

IDEAYA Biosciences, Inc. engages in the research and development of oncology-focused precision medicine. The company is headquartered in South San Francisco, California and currently employs 81 full-time employees. The company went IPO on 2019-05-23. The firm is focused on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its lead synthetic lethality product candidate, IDE397, is a clinical-stage methionine adenosyltransferase 2a (MAT2A) inhibitor for patients with solid tumors having methylthioadenosine phosphorylase (MTAP) deletions. Its clinical-stage product candidate, darovasertib (IDE196), is a protein kinase C (PKC), inhibitor that is being evaluated as a synthetic lethal combination therapy in patients having genetically defined cancers having GNAQ or GNA11 gene mutations. Its pipeline also includes preclinical research programs directed to synthetic lethality targets PARG, Pol Theta, Werner Helicase, and certain deoxyribonucleic acid (DNA) damage targets. The PARG program is for patients having tumors with a defined biomarker based on genetic mutations.

Contact

CALIFORNIA
South San Francisco
7000 Shoreline Ct Ste 350
+16504436209.0
www.ideayabio.com

IPO

2019-05-23

Employees

81

Officers

President, CEO & Director
Mr. Yujiro S. Hata
Principal Accounting Officer, Senior VP and Head of Finance & Investor Relations
Mr. Andres Ruiz Briseno CPA
Chief Scientific Officer
Dr. Michael A. White Ph.D.
Chief Medical Officer
Dr. Darrin M. Beaupre M.D., Ph.D.
Chief Technology Officer
Dr. Paul A. Barsanti Ph.D.
Senior VP & General Counsel
Mr. Douglas B. Snyder
Show More
Vice President & Head of Human Resources
Ms. Francine Zelaya
Chief of Staff & Clinical Development
Mr. Mick O'Quigley
Chief Business Officer
Mr. Daniel A. Simon
Show Less

See Also

Discover More
What is the Intrinsic Value of one IDYA stock?

The intrinsic value of one IDYA stock under the Base Case scenario is 11.022 USD.

Is IDYA stock undervalued or overvalued?

Compared to the current market price of 26.995 USD, IDEAYA Biosciences Inc is Overvalued by 59%.

Back to Top